Apogee Therapeutics, Inc. Common Stock (APGE) Sentiment
30-day SentiSense Score -0.17 · Neutral · ▬ steady · as of 2026-09-23
APGE sentiment is neutral (30-day SentiSense Score 0) and holding steady; today's read of 0 is in line with its 30-day average. Attention averages ~5 mentions/day (1 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- -0.17
- Today's read
- 0 (Neutral)
- Mentions / day (30-day avg)
- 5 (1 today)
Where the conversation is happening
- News
- Bullish · 63% of mentions
- X
- Bearish · 24% of mentions
- Neutral · 12% of mentions
Related tickers
What's driving it
- AbbVie closes its $10.9 billion Apogee Therapeutics acquisition, adding a late-stage immunology pipeline (+0.08)
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion in Cash (+0.38)
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion (+0.41)
Live SentiSense Score, sentiment history, and per-source breakdown for Apogee Therapeutics, Inc. Common Stock on SentiSense.
See how APGE's sector compares in the market sentiment heatmap